Share This

PR Newswire Asia's news

 |   Title only   |   Print    Next page > 
     
Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC
Monotherapy Ivonescimab Achieved Clinically Meaningful PFS Benefit in HARMONi-2 Trial Conducted by Akeso PFS Improvement Was Observed Broadly in Patients Across Subgroups, including PD-L1 Low and ...
2024-05-31T    Biotechnology   Health Care/Hospital 
UNLIMEAT Kimbap Products Now Available via DoorDash's DashMart
-  UNLIMEAT is now being sold on DoorDash's DashMart, the company's online convenience store, to make UNLIMEAT Kimbap available nationwide. ...
2024-05-31T    Food/Beverages   Retail 
SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care
New collective intelligence network to enable the most advanced research in oncology in support of precision medicine ...
2024-05-31T    Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
Hanwha named to TIME's list of the TIME100 Most Influential Companies
The list, which features companies making an extraordinary impact around the world, honored Hanwha as a "Titan," noting its growing presence in the industries of defense and clean energy ...
2024-05-31T    Alternative Energies   Environmental Products & Services   Green Technology 
Diving Deep: Divirod Partners with Hospitality Groups to Take on Climate Change and Water Data Scarcity with New Global Coastal Observation Network Initiative
BOULDER, Colo. , May 30, 2024 /PRNewswire/ -- As the risks posed by climate change increase, the lack of comprehensive water data and gaps in coastal monitoring infrastructure pose significant challenges ...
2024-05-30T    Computer/Electronics   Environmental Products & Services   Travel 
Speakly AI Shines at VivaTech 2024 with Its LLM-based Conversation Intelligence Solution
MOUNTAIN VIEW, Calif.  , May 30, 2024 /PRNewswire/ -- Speakly AI, a pioneer in conversation intelligence solutions powered by large language models, focusing on enhancing sales and service efficiency, ...
2024-05-30T    Computer/Electronics   Trade show news 
CIMC Vehicles's H Share Buy-back Offer Closed
H Shares to Delist at 4 pm on 3 June ...
2024-05-30T    Banking/Financial Service   Transportation 
"Disrupt" introduces Disrupt Health Impact Fund with leading business groups in Thailand to invest in HealthTech startups globally
BANGKOK , May 30, 2024 /PRNewswire/ -- Disrupt Technology Venture ("Disrupt") announced the introduction of Disrupt Health Impact Fund with the first group of co-investment partners from leading ...
2024-05-30T    Banking/Financial Service   Health Care/Hospital   Medical Equipment 
ActiveOps becomes Official Analytics Partner to Great Britain 7s Rugby team
Highlighting the necessity of data-driven decision-making as a central tenet to both athletes on the pitch and employees in the workforce Agreement enables ActiveOps to provide analytics expertise ...
2024-05-30T    Computer Software   Computer/Electronics   Sports 
TOOsonix receives MDR CE Mark for its new oncology and dermatology device
The EU Medical Device Regulation CE certification approves that the most common types of skin cancer and a wide range of skin diseases and conditions can be treated in less than 90 seconds. ...
2024-05-30T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
  Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.